查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1930104

全球診斷人工智慧（AI）市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考量因素以及未來預測（2026-2034）

AI in Diagnostics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 159 Pages | 商品交期: 請詢問到貨日

價格

診斷人工智慧（AI）市場成長因素

醫療保健行業的快速數字化轉型、日益加重的疾病負擔以及熟練醫療專業人員的短缺正在推動全球診斷人工智慧（AI）市場的快速增長。 根據 Fortune Business Insights 預測，2025 年該市場規模預計將達到 70.3 億美元，2026 年將達到 101.2 億美元。到 2034 年，該市場預計將達到 2,096.4 億美元，2026 年至 2034 年的複合年增長率 (CAGR) 高達 46.06%。北美地區在 2025 年將佔市場主導地位，市場佔有率達到 50.84%，這得益於人工智慧的廣泛應用、先進的醫療基礎設施以及眾多領先科技公司的入駐。

市場概覽

診斷人工智慧 (AI) 融合了機器學習 (ML)、深度學習和自然語言處理 (NLP) 技術，用於分析大量醫療數據，包括診斷影像、檢測結果、電子病歷和基因組資訊。 AI 可顯著縮短診斷時間，提高診斷準確度，並有助於早期發現癌症、心血管疾病、神經系統疾病和其他病症。 這些優勢正推動人工智慧診斷解決方案在醫院、影像中心和研究機構中廣泛應用。

慢性病日益增多以及全球醫療專業人員（尤其是放射科醫生和病理學家）短缺是市場成長的關鍵驅動因素。例如，英國報告稱，專科放射科醫生缺口高達33%，預計到2025年，這種情況將進一步惡化。這進一步增加了對人工智慧診斷支援系統的需求。

市場驅動因素

主要成長驅動因素是全球慢性病負擔日益惡化。根據2024年發布的數據，美國將有超過31萬名女性和2800名男性被診斷出患有侵襲性乳癌，這凸顯了早期準確診斷的必要性。人工智慧工具可以透過識別傳統方法常常忽略的細微疾病模式來輔助臨床醫生。

此外，人工智慧可以透過自動化日常任務、減輕臨床醫生的工作量和提高診斷效率來幫助緩解勞動力短缺問題。這在放射學和病理學領域尤其重要，因為這些領域的需求持續超過供應。

市場限制因子

儘管成長前景廣闊，但醫療專業人員的抵觸情緒仍然是一個主要限制因素。對工作崗位流失的擔憂、人工智慧決策缺乏透明度以及對診斷可靠性的疑慮都在減緩人工智慧的普及。透過培訓、驗證研究和明確的監管規定來建立信任，對於克服這些障礙至關重要。

市場機會

人工智慧在眼科、自體免疫疾病和傳染病診斷等尚未開發的專科領域的擴展，蘊藏著巨大的機會。 2024 年 5 月，Lumibird Medical 發布了一款由人工智慧驅動的乾眼症診斷平台，顯示人工智慧在傳統放射學和腫瘤學以外的應用可以開闢新的收入來源。

市場挑戰

監管合規和資料隱私是關鍵挑戰。人工智慧診斷工具必須遵守 HIPAA 和 GDPR 等嚴格法規，以確保資料安全、透明和合乎倫理的使用。日益嚴重的網路威脅和資料外洩進一步增加了合規成本和實施複雜性。

市場趨勢

一個值得注意的趨勢是，越來越多的資金和政府主導的措施正在加速人工智慧在診斷領域的應用。 2024 年 10 月，Ataraxis AI 獲得了 400 萬美元的種子輪融資，用於開發精準診斷工具。 同樣，英國國家醫療服務體系 (NHS) 已撥款 2,680 萬美元用於部署人工智慧影像技術，以快速診斷癌症、中風和心臟病。

細分市場分析

  • 依組件劃分：在持續的技術創新和合作的推動下，解決方案/軟體細分市場將在 2024 年佔最大佔有率。同時，服務細分市場預計將保持穩定成長。
  • 依技術劃分：能夠分析複雜醫療資料集的機器學習技術佔主導地位，其次是自然語言處理 (NLP) 和電腦視覺技術。
  • 依專科劃分：由於癌症發病率上升和對預測性診斷的需求不斷增長，腫瘤學正在推動市場成長。神經病學和病理學也呈現強勁增長。
  • 依最終用戶劃分：由於工作量增加和對快速診斷的需求不斷增長，實驗室和影像中心處於領先地位。同時，醫院和診所也迅速採用人工智慧技術。

區域展望

  • 北美：早期人工智慧應用和強大的產業基礎推動市場規模在2025年達到35.8億美元。
  • 歐洲：政府資助和醫院層面的人工智慧應用正在推動市場成長。
  • 亞太地區：由於慢性病發病率上升、放射科醫生短缺以及人工智慧在中國、日本、印度和其他地區的快速普及，預計亞太市場將實現最高的複合年增長率。
  • 拉丁美洲、中東和非洲：由於遠端診斷的興起和策略合作的加強，預計市場將保持溫和成長。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 與診斷人工智慧 (AI) 相關的技術進步
  • 主要國家的監管狀況
  • 採用和實施基於人工智慧的解決方案所面臨的挑戰
  • 醫療保健市場人工智慧的關鍵績效指標
  • 主要產業趨勢：併購、業務合作等
  • 影響COVID-19 對市場的影響

第五章 全球診斷人工智慧市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依組件劃分
    • 解決方案/軟體
    • 服務
  • 市場分析、洞察與預測：依技術劃分
    • 機器學習
    • 自然語言處理 (NLP)
    • 其他
  • 市場分析、洞察與預測：依專科劃分
    • 腫瘤科
    • 神經科
    • 病理科
    • 其他
  • 市場分析、洞察與預測：依最終用戶劃分
    • 醫院和診所
    • 診斷與影​​像中心
    • 其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美診斷人工智慧市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲診斷人工智慧市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪的納維亞
    • 其他歐洲國家國家/地區

第八章 亞太地區診斷人工智慧市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章 拉丁美洲診斷人工智慧市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區

第十章 中東與非洲診斷人工智慧市場分析：洞察與預測（2021-2034）

  • 依國家/地區
    • 海灣合作委員會 (GCC)
    • 南非
    • 中東和非洲其他地區

第十一章 競爭分析

  • 全球市佔率分析 (2025)
  • 公司簡介
    • Amazon.com, Inc.
    • Microsoft Corporation
    • NVIDIA Corporation
    • Google
    • Siemens Healthcare Private Limited
    • Aidoc
    • PathAI, Inc.
    • Digital Diagnostics Inc.
    • Tempus AI
    • Qure.ai
Product Code: FBI111351

Growth Factors of AI in diagnostics Market

The global AI in diagnostics market is witnessing exponential growth due to rapid digital transformation in healthcare, increasing disease burden, and shortages of skilled medical professionals. According to Fortune Business Insights, the market was valued at USD 7.03 billion in 2025 and is projected to grow to USD 10.12 billion in 2026. By 2034, the market is expected to reach USD 209.64 billion, registering an exceptional CAGR of 46.06% during 2026-2034. North America dominated the market in 2025 with a 50.84% share, supported by strong AI adoption, advanced healthcare infrastructure, and the presence of leading technology players.

Market Overview

Artificial intelligence in diagnostics integrates machine learning (ML), deep learning, and natural language processing (NLP) to analyze large volumes of medical data, including imaging scans, laboratory results, electronic health records, and genomic information. AI significantly reduces diagnostic time, improves accuracy, and enables early detection of diseases such as cancer, cardiovascular disorders, and neurological conditions. These advantages are driving widespread adoption of AI-based diagnostic solutions across hospitals, imaging centers, and research institutions.

The rising prevalence of chronic diseases and the global shortage of healthcare professionals, particularly radiologists and pathologists, are key contributors to market growth. For instance, the UK reported a 33% shortage of consultant radiologists, expected to worsen by 2025, reinforcing the need for AI-driven diagnostic support systems.

Market Drivers

A major growth driver is the increasing burden of chronic diseases worldwide. According to data published in 2024, over 310,000 women and 2,800 men in the U.S. are expected to be diagnosed with invasive breast cancer, highlighting the need for early and precise diagnostics. AI-powered tools assist clinicians by identifying subtle disease patterns that may be missed by conventional methods.

Additionally, AI helps mitigate workforce shortages by automating routine tasks, reducing clinician workload, and improving diagnostic efficiency. This is especially critical in radiology and pathology, where demand continues to exceed supply.

Market Restraints

Despite strong growth prospects, reluctance among medical practitioners remains a key restraint. Concerns related to job displacement, lack of transparency in AI decision-making, and doubts about diagnostic reliability slow adoption. Building trust through training, validation studies, and regulatory clarity is essential to overcome these barriers.

Market Opportunities

The expansion of AI into untapped specialty areas, such as ophthalmology, autoimmune diseases, and infectious disease diagnostics, presents significant opportunities. In May 2024, Lumibird Medical launched an AI-enabled dry eye diagnostic platform, highlighting how AI adoption beyond traditional radiology and oncology can unlock new revenue streams.

Market Challenges

Regulatory compliance and data privacy pose major challenges. AI diagnostic tools must comply with stringent regulations such as HIPAA and GDPR, ensuring data security, transparency, and ethical use. Rising cyber threats and data breaches further increase compliance costs and implementation complexity.

Market Trends

A prominent trend is increasing funding and government initiatives to accelerate AI adoption in diagnostics. In October 2024, Ataraxis AI secured USD 4.0 million in seed funding to develop precision diagnostic tools. Similarly, the UK NHS allocated USD 26.8 million to deploy AI imaging technologies for faster diagnosis of cancer, stroke, and heart disease.

Segmentation Analysis

  • By Component: The solutions/software segment held the largest share in 2024 due to continuous innovation and collaborations, while services are expected to grow steadily.
  • By Technology: Machine learning dominates due to its ability to analyze complex healthcare datasets, followed by NLP and computer vision technologies.
  • By Specialty: Oncology leads the market, driven by rising cancer prevalence and demand for predictive diagnostics. Neurology and pathology also show strong growth.
  • By End User: Diagnostics & imaging centers dominate due to increasing workload and demand for faster diagnosis, while hospitals and clinics are adopting AI at a rapid pace.

Regional Outlook

  • North America: Market size reached USD 3.58 billion in 2025, driven by early AI adoption and strong industry presence.
  • Europe: Growth supported by government funding and hospital-level AI deployments.
  • Asia Pacific: Expected to register the highest CAGR due to rising chronic diseases, shortage of radiologists, and rapid AI integration in countries like China, Japan, and India.
  • Latin America & Middle East & Africa: Moderate growth driven by increasing remote diagnostics and strategic collaborations.

Competitive Landscape

Key players include Microsoft Corporation, Google, NVIDIA, Siemens Healthineers, Aidoc, PathAI, Digital Diagnostics, Tempus AI, and Qure.ai. These companies focus on strategic partnerships, cloud-based AI platforms, and advanced diagnostic algorithms to strengthen their market position.

Conclusion

The global AI in diagnostics market is set for transformative expansion, growing from USD 7.03 billion in 2025 to USD 209.64 billion by 2034. Driven by rising chronic disease prevalence, workforce shortages, and rapid technological advancements, AI is reshaping diagnostic accuracy and efficiency. While regulatory challenges and practitioner hesitancy remain, increasing investments, government initiatives, and expanding applications across specialties will ensure sustained growth. North America leads the market, while Asia Pacific offers the fastest growth potential, making AI in diagnostics a critical pillar of future healthcare systems.

Segmentation By Component

  • Solutions/ Software
  • Services

By Technology

  • Machine Learning
  • Natural Language Processing (NLP)
  • Others

By Specialty

  • Oncology
  • Neurology
  • Pathology
  • Others

By End-user

  • Hospitals & Clinics
  • Diagnostics & Imaging Centers
  • Others

By Region

  • North America (By Component, Technology, Specialty, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Component, Technology, Specialty, End-user, and Country/sub-region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Component, Technology, Specialty, End-user, and Country/sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Component, Technology, Specialty, End-user, and Country/sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Component, Technology, Specialty, End-user, and Country/sub-region)
    • GCC
    • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements Pertaining to the Artificial Intelligence in Diagnostics
  • 4.2. Regulatory Scenario for Key Countries
  • 4.3. Challenges Faced During Adoption and Implementation of AI-based Solutions
  • 4.4. Key Performance Indicators for Artificial Intelligence in the Healthcare Market
  • 4.5. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.
  • 4.6. Impact of COVID-19 on the Market

5. Global AI in Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Component
    • 5.1.1. Solutions/ Software
    • 5.1.2. Services
  • 5.2. Market Analysis, Insights and Forecast - By Technology
    • 5.2.1. Machine Learning
    • 5.2.2. Natural Language Processing (NLP)
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Specialty
    • 5.3.1. Oncology
    • 5.3.2. Neurology
    • 5.3.3. Pathology
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By End-user
    • 5.4.1. Hospitals & Clinics
    • 5.4.2. Diagnostics & Imaging Centers
    • 5.4.3. Others
  • 5.5. Market Analysis, Insights and Forecast - Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America AI in Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Component
    • 6.1.1. Solutions/ Software
    • 6.1.2. Services
  • 6.2. Market Analysis, Insights and Forecast - By Technology
    • 6.2.1. Machine Learning
    • 6.2.2. Natural Language Processing (NLP)
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Specialty
    • 6.3.1. Oncology
    • 6.3.2. Neurology
    • 6.3.3. Pathology
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By End-user
    • 6.4.1. Hospitals & Clinics
    • 6.4.2. Diagnostics & Imaging Centers
    • 6.4.3. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe AI in Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Component
    • 7.1.1. Solutions/ Software
    • 7.1.2. Services
  • 7.2. Market Analysis, Insights and Forecast - By Technology
    • 7.2.1. Machine Learning
    • 7.2.2. Natural Language Processing (NLP)
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By Specialty
    • 7.3.1. Oncology
    • 7.3.2. Neurology
    • 7.3.3. Pathology
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By End-user
    • 7.4.1. Hospitals & Clinics
    • 7.4.2. Diagnostics & Imaging Centers
    • 7.4.3. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.5.1. Germany
    • 7.5.2. U.K.
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific AI in Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Component
    • 8.1.1. Solutions/ Software
    • 8.1.2. Services
  • 8.2. Market Analysis, Insights and Forecast - By Technology
    • 8.2.1. Machine Learning
    • 8.2.2. Natural Language Processing (NLP)
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By Specialty
    • 8.3.1. Oncology
    • 8.3.2. Neurology
    • 8.3.3. Pathology
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By End-user
    • 8.4.1. Hospitals & Clinics
    • 8.4.2. Diagnostics & Imaging Centers
    • 8.4.3. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.5.1. China
    • 8.5.2. Japan
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America AI in Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Component
    • 9.1.1. Solutions/ Software
    • 9.1.2. Services
  • 9.2. Market Analysis, Insights and Forecast - By Technology
    • 9.2.1. Machine Learning
    • 9.2.2. Natural Language Processing (NLP)
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By Specialty
    • 9.3.1. Oncology
    • 9.3.2. Neurology
    • 9.3.3. Pathology
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Hospitals & Clinics
    • 9.4.2. Diagnostics & Imaging Centers
    • 9.4.3. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa AI in Diagnostics Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Component
    • 10.1.1. Solutions/ Software
    • 10.1.2. Services
  • 10.2. Market Analysis, Insights and Forecast - By Technology
    • 10.2.1. Machine Learning
    • 10.2.2. Natural Language Processing (NLP)
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By Specialty
    • 10.3.1. Oncology
    • 10.3.2. Neurology
    • 10.3.3. Pathology
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By End-user
    • 10.4.1. Hospitals & Clinics
    • 10.4.2. Diagnostics & Imaging Centers
    • 10.4.3. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Amazon.com, Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Microsoft Corporation
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. NVIDIA Corporation
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Google
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Siemens Healthcare Private Limited
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Aidoc
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. PathAI, Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Digital Diagnostics Inc.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Tempus AI
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Qure.ai
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global AI in Diagnostics Market Revenue (USD billion) Forecast, by Component, 2021-2034
  • Table 2: Global AI in Diagnostics Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 3: Global AI in Diagnostics Market Revenue (USD billion) Forecast, by Specialty, 2021-2034
  • Table 4: Global AI in Diagnostics Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 5: Global AI in Diagnostics Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America AI in Diagnostics Market Revenue (USD billion) Forecast, by Component, 2021-2034
  • Table 7: North America AI in Diagnostics Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 8: North America AI in Diagnostics Market Revenue (USD billion) Forecast, by Specialty, 2021-2034
  • Table 9: North America AI in Diagnostics Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 10: North America AI in Diagnostics Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe AI in Diagnostics Market Revenue (USD billion) Forecast, by Component, 2021-2034
  • Table 12: Europe AI in Diagnostics Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 13: Europe AI in Diagnostics Market Revenue (USD billion) Forecast, by Specialty, 2021-2034
  • Table 14: Europe AI in Diagnostics Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 15: Europe AI in Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific AI in Diagnostics Market Revenue (USD billion) Forecast, by Component, 2021-2034
  • Table 17: Asia Pacific AI in Diagnostics Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 18: Asia Pacific AI in Diagnostics Market Revenue (USD billion) Forecast, by Specialty, 2021-2034
  • Table 19: Asia Pacific AI in Diagnostics Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 20: Asia Pacific AI in Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America AI in Diagnostics Market Revenue (USD billion) Forecast, by Component, 2021-2034
  • Table 22: Latin America AI in Diagnostics Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 23: Latin America AI in Diagnostics Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 24: Latin America AI in Diagnostics Market Revenue (USD billion) Forecast, by Specialty, 2021-2034
  • Table 25: Latin America AI in Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa AI in Diagnostics Market Revenue (USD billion) Forecast, by Component, 2021-2034
  • Table 27: Middle East & Africa AI in Diagnostics Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 28: Middle East & Africa AI in Diagnostics Market Revenue (USD billion) Forecast, by Specialty, 2021-2034
  • Table 29: Middle East & Africa AI in Diagnostics Market Revenue (USD billion) Forecast, by End-user 2021-2034
  • Table 30: Middle East & Africa AI in Diagnostics Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global AI in Diagnostics Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global AI in Diagnostics Market Value Share (%), by Component, 2025 & 2034
  • Figure 3: Global AI in Diagnostics Market Value Share (%), by Technology, 2025 & 2034
  • Figure 4: Global AI in Diagnostics Market Value Share (%), by Specialty, 2025 & 2034
  • Figure 5: Global AI in Diagnostics Market Value Share (%), by End-user, 2025 & 2034
  • Figure 6: Global AI in Diagnostics Market Value (USD billion), by Region, 2025 & 2034
  • Figure 7: North America AI in Diagnostics Market Value (USD billion), by Component, 2025 & 2034
  • Figure 8: North America AI in Diagnostics Market Value Share (%), by Component, 2025
  • Figure 9: North America AI in Diagnostics Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 10: North America AI in Diagnostics Market Value Share (%), by Technology, 2025
  • Figure 11: North America AI in Diagnostics Market Value (USD billion), by Specialty, 2025 & 2034
  • Figure 12: North America AI in Diagnostics Market Value Share (%), by Specialty, 2025
  • Figure 13: North America AI in Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 14: North America AI in Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 15: North America AI in Diagnostics Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America AI in Diagnostics Market Value Share (%), By Country, 2025
  • Figure 17: Europe AI in Diagnostics Market Value (USD billion), by Component, 2025 & 2034
  • Figure 18: Europe AI in Diagnostics Market Value Share (%), by Component, 2025
  • Figure 19: Europe AI in Diagnostics Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 20: Europe AI in Diagnostics Market Value Share (%), by Technology, 2025
  • Figure 21: Europe AI in Diagnostics Market Value (USD billion), by Specialty, 2025 & 2034
  • Figure 22: Europe AI in Diagnostics Market Value Share (%), by Specialty, 2025
  • Figure 23: Europe AI in Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 24: Europe AI in Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 25: Europe AI in Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe AI in Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific AI in Diagnostics Market Value (USD billion), by Component, 2025 & 2034
  • Figure 28: Asia Pacific AI in Diagnostics Market Value Share (%), by Component, 2025
  • Figure 29: Asia Pacific AI in Diagnostics Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 30: Asia Pacific AI in Diagnostics Market Value Share (%), by Technology, 2025
  • Figure 31: Asia Pacific AI in Diagnostics Market Value (USD billion), by Specialty, 2025 & 2034
  • Figure 32: Asia Pacific AI in Diagnostics Market Value Share (%), by Specialty, 2025
  • Figure 33: Asia Pacific AI in Diagnostics Market Value (USD billion),by End-user, 2025 & 2034
  • Figure 34: Asia Pacific AI in Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 35: Asia Pacific AI in Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific AI in Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America AI in Diagnostics Market Value (USD billion), by Component, 2025 & 2034
  • Figure 38: Latin America AI in Diagnostics Market Value Share (%), by Component, 2025
  • Figure 39: Latin America AI in Diagnostics Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 40: Latin America AI in Diagnostics Market Value Share (%), by Technology, 2025
  • Figure 41: Latin America AI in Diagnostics Market Value (USD billion), by Specialty, 2025 & 2034
  • Figure 42: Latin America AI in Diagnostics Market Value Share (%), by Specialty, 2025
  • Figure 43: Latin America AI in Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 44: Latin America AI in Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 45: Latin America AI in Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America AI in Diagnostics Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa AI in Diagnostics Market Value (USD billion), by Component, 2025 & 2034
  • Figure 48: Middle East & Africa AI in Diagnostics Market Value Share (%), by Component, 2025
  • Figure 49: Middle East & Africa AI in Diagnostics Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 50: Middle East & Africa AI in Diagnostics Market Value Share (%), by Technology, 2025
  • Figure 51: Middle East & Africa AI in Diagnostics Market Value (USD billion), by Specialty, 2025 & 2034
  • Figure 52: Middle East & Africa AI in Diagnostics Market Value Share (%), by Specialty, 2025
  • Figure 53: Middle East & Africa AI in Diagnostics Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 54: Middle East & Africa AI in Diagnostics Market Value Share (%), by End-user, 2025
  • Figure 55: Middle East & Africa AI in Diagnostics Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa AI in Diagnostics Market Value Share (%), By Country/ Sub-region, 2025

Figure 57: Global AI in Diagnostics Market Share (%), By Company, 2025